Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 54Breast Neoplasms 43Neoplasms 4Salivary Gland Neoplasms 3Triple Negative Breast Neoplasms 2Prostate Adenocarcinoma 2Advanced Breast Cancer 2Recurrence 1PSA Level Greater Than Two 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lymphatic Metastasis 1Inflammatory Breast Neoplasms 1Hormone-sensitive Metastatic Breast Cancer 1Hormone Sensitive Prostate Cancer 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1HER2-positive Breast Cancer 1HER2 Negative Breast Cancer 1Fallopian Tube Neoplasms 1Castrate Sensitive Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms, Male 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 2encorafenib 1binimetinib 1alovudine 1X-Rays 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Platinum 1Nivolumab 1Metastasectomy 1Magnetic Resonance Spectroscopy 1Leuprolide 1Ipilimumab 1Goserelin 1Drug Therapy 1Docetaxel 1Axitinib 1Androgen Antagonists 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphatic Metastasis × Goserelin × Clear all
NCT01076335 2016-09-19

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
40 enrolled 3 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡